Resonate Blends, Inc. (KOAN) Fair Value 2026

KOAN · Drug Manufacturers - Specialty & Generic ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.4 /10

32 fundamental signals · 1 models active

Value Trap Risk

SAFE (21/100)

Quick Summary — As of 2026-08-27, Resonate Blends, Inc. (KOAN) trades at $0.00. QOC: 4.4/10. Value Trap Risk: 21/100 (SAFE). 1/13 models active.

Key Facts

Ticker
KOAN
Price
$0.00
Quality Score
4.4/10
Value Trap Risk
21/100
Models Active
1/13
Last Updated
Strength: PWERM suggests +278.7% upside with 28% confidence
Risk: Below-average Quality Score of 4.4/10 signals weak fundamentals

What Fair Value Does Each Model Give KOAN?

1 Intrinsic Value Models vs. Current Price ($0.00)

Core Models (Unlocked)
Model Fair Value Upside
Option-Based · Medium Conviction
 $0.00 +278.7%

All Models Active

All 1 models are displayed above.

What Is Resonate Blends, Inc. (KOAN) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the weight of evidence tilts decidedly bullish for Resonate Blends, Inc.. Trading at $0.00 against an estimated intrinsic value of $0.00, 1 of 1 active models flag meaningful upside of +278.7% at the median.

What Do the Models Say About KOAN?

1 of 13 models are currently active for KOAN. All 1 active models suggest the stock trades below fair value. See which stocks rank higher →

How Does KOAN Rank in Drug Manufacturers - Specialty & Generic?

Among 110 Drug Manufacturers - Specialty & Generic stocks, KOAN ranks #93 by Quality of Company score. CirclFi's QOC score of 4.4/10 evaluates 32 fundamental signals. A score of 4.4 reflects mixed fundamentals.

See all Most Undervalued Drug Manufacturers - Specialty & Generic Stocks →

Within the Drug Manufacturers - Specialty & Generic space, Resonate Blends, Inc. competes in an environment where revenue per drug often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is KOAN a Value Trap?

CirclFi's Value Trap algorithm assigns KOAN a score of 21/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for Resonate Blends, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Resonate Blends, Inc. is rated at 4.4/10. This moderate-tier score shows mixed signals across our quality framework with notable weaknesses.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every KOAN valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across KOAN's 1 active models, average confidence is 28%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Resonate Blends, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Drug Manufacturers - Specialty & Generic Stocks Should You Also Analyze?

11 related Drug Manufacturers - Specialty & Generic stocks with 13-model coverage

CTORCitius Oncology, Inc.QOC 4.4CBIHCannabis Bioscience International Holdings, Inc.QOC 4.3BSPKBespoke Extracts, Inc.QOC 4.5BUDZWEED, Inc.QOC 4.2CPHIChina Pharma Holdings, Inc.QOC 4.6GRPSGold River Productions, Inc.QOC 4.1PAHCPhibro Animal Health CorporationQOC 8.7AKBAAkebia Therapeutics, Inc.QOC 6.6TKNOAlpha Teknova, Inc.QOC 5.8UTHRUnited Therapeutics CorporationQOC 9.6AMPHAmphastar Pharmaceuticals, Inc.QOC 9.4

Read investment analysis: CTOR · CBIH · BSPK · BUDZ · CPHI · GRPS · PAHC · AKBA · TKNO · UTHR · AMPH

Which Other Stocks Have a Similar Quality Score to KOAN?

7 companies across all industries closest to KOAN’s Quality of Company score of 4.4/10.

EVOHEvoAir Holdings Inc.QOC 4.4KBLBKraig Biocraft Laboratories, Inc.QOC 4.4IBOImpact BioMedical Inc.QOC 4.4OZSCOzop Energy Solutions, Inc.QOC 4.4SHFSSHF Holdings, Inc.QOC 4.4SNRGSusGlobal Energy Corp.QOC 4.4NVDANVIDIA CorporationQOC 10.0

Read investment analysis: EVOH · KBLB · IBO · OZSC · SHFS · SNRG · NVDA

Where Does KOAN Sit in CirclFi's Drug Manufacturers - Specialty & Generic Rankings?

KOAN is ranked against every other Drug Manufacturers - Specialty & Generic stock CirclFi covers in each of these screens.

See all Drug Manufacturers - Specialty & Generic stocks ranked →

What Else Do Investors Ask About Resonate Blends, Inc.’s Valuation?

What is Resonate Blends, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Resonate Blends, Inc. (KOAN). The Quality of Company score is 4.4/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is KOAN overvalued or undervalued right now?

At $0.00, 1 of 1 active models suggest KOAN may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Resonate Blends, Inc.'s business model in Drug Manufacturers - Specialty & Generic.

What does a Quality of Company score of 4.4 mean for KOAN?

Resonate Blends, Inc.'s QOC of 4.4/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on KOAN?

CirclFi analyzes KOAN with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is KOAN a value trap in 2026?

Resonate Blends, Inc.'s Value Trap score is 21/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Resonate Blends, Inc. (KOAN) a Quality of Company score of 4.4/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/KOAN/ · Methodology
Primary sources for this KOAN valuation
  • Financial statements: Resonate Blends, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0000897078) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for KOAN as of ; valuations recomputed .